Concepedia

Larry Yet

LY

Statistics

Publications

17

Citations

911

H-Index

16

Active since

1995

Affiliations

Albany Molecular Research (United States)(Current)

Merck & Co., Inc., Rahway, NJ, USA (United States)

Albany Molecular Research (Singapore)

University of South Alabama

University of Alabama at Birmingham

Larry Yet is an author at Albany Molecular Research (United States) specializing in pharmacology, medicinal chemistry, and drug discovery.

ORCID

Publications per year

1995–2017

17

Publications

17

Recent Developments in Catalytic Asymmetric Strecker-Type Reactions

Larry Yet · Angewandte Chemie International Edition · 2001 · 253 citations

, , +10

Free radicals in the synthesis of medium-sized rings

Larry Yet · Tetrahedron · 1999 · 217 citations

, , +5

Phosphodiesterase 10A: a novel target for selective inhibition of colon tumor cell growth and β-catenin-dependent TCF transcriptional activity

Nailin Li, Kyongbum Lee, Yaguang Xi et al. · Oncogene · 2014 · 72 citations · Full text

, , +14

Phosphodiesterase 10A is overexpressed in lung tumor cells and inhibitors selectively suppress growth by blocking β-catenin and MAPK signaling

Bing Zhu, Ashley S. Lindsey, Nan Li et al. · Oncotarget · 2017 · 47 citations · Full text

, , +15

Microwave-assisted organic synthesis of 3-substituted-imidazo[1,5-a]pyridines

Venkata Satyanarayana Arvapalli, Guangwu Chen, S. A. Kosarev et al. · Tetrahedron Letters · 2009 · 44 citations

, , +8

1–5 of 17